Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for hemophilia A with vascular abnormality has been reported in the published literature.
No clinical trials have been registered for hemophilia A with vascular abnormality.
7 publications have been identified in PubMed for hemophilia A with vascular abnormality. Research spans Review / Meta-Analysis (29%), Basic Science / Preclinical (29%), and Gene Therapy / Novel Therapeutics (29%).
Prameyllawati DM (2026). [PMID: 41541608](https://pubmed.ncbi.nlm.nih.gov/41541608/). *Res Pract Thromb Haemost*. [Gene Therapy / Novel Therapeutics]
Cygan PH (2026). [PMID: 41679506](https://pubmed.ncbi.nlm.nih.gov/41679506/). *J Thromb Haemost*. [Diagnostic / Biomarker]
Basta M (2026). [PMID: 32491315](https://pubmed.ncbi.nlm.nih.gov/32491315/). *Unknown Journal*. [Basic Science / Preclinical]
Sakata A (2025). [PMID: 40055470](https://pubmed.ncbi.nlm.nih.gov/40055470/). *Communications biology*. [Basic Science / Preclinical]
Dolan G (2025). [PMID: 38733982](https://pubmed.ncbi.nlm.nih.gov/38733982/). *Semin Thromb Hemost*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
Online Mendelian Inheritance in Man
Nemes A (2025). [PMID: 41089783](https://pubmed.ncbi.nlm.nih.gov/41089783/). *Reviews in cardiovascular medicine*. [Review / Meta-Analysis]
Togashi T (2024). [PMID: 39508105](https://pubmed.ncbi.nlm.nih.gov/39508105/). *Arteriosclerosis, thrombosis, and vascular biology*. [Gene Therapy / Novel Therapeutics]
AI-curated news mentioning hemophilia A with vascular abnormality
Updated Feb 6, 2026
Pfizer has initiated a Phase 3 trial for giroctocogene fitelparvovec (PF-07055480), a gene therapy targeting severe hemophilia A. This advancement reflects Pfizer's commitment to developing transformative treatments for rare diseases.